Luo, Yingying

Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management

Amiel, S. A., Aschner, P., Childs, B., Cryer, P. E., de Galan, B. E., Frier, B. M., Gonder-Frederick, L., Heller, S. R., Jones, T., Khunti, K., et al. (2019) · The Lancet Diabetes & Endocrinology

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 526

Predicting cardiovascular outcomes in Chinese patients with type 2 diabetes by combining risk factor trajectories and machine learning algorithm: a cohort study

Huang, Q., Zou, X., Lian, Z., Zhou, X., Han, X., Luo, Y., Chen, S., Wang, Y., Wu, S., & Ji, L. (2025) · Cardiovascular Diabetology

Diabetes, Cardiovascular Risks, and LipoproteinsArtificial Intelligence in Healthcare

Cited by 15

Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes

Luo, Y., Paul, S. K., Zhou, X., Chang, C., Chen, W., Guo, X., Yang, J., Ji, L., & Wang, H. (2017) · Journal of Diabetes Research

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 13

Weight reduction and the risk of gallbladder and biliary disease: A systematic review and meta‐analysis of randomized clinical trials

Yang, W., Wu, H., Cai, X., Lin, C., Luo, Y., Hu, S., Li, Z., Jiao, R., Bai, S., Liu, G., et al. (2024) · Obesity Reviews

Gallbladder and Bile Duct DisordersPharmacology and Obesity Treatment

Cited by 11

Machine learning for the prediction of atherosclerotic cardiovascular disease during 3‐year follow up in Chinese type 2 diabetes mellitus patients

Ding, J., Luo, Y., Shi, H., Chen, R., Luo, S., Yang, X., Xiao, Z., Liang, B., Yan, Q., Xu, J., et al. (2023) · Journal of Diabetes Investigation

Artificial Intelligence in HealthcareMachine Learning in Healthcare

Cited by 9